FDC make modest beginning in 1936, with marketing of vitamins and a range of prescription formulations. FDC set up its first formulations manufacturing facility in 1949. Subsequently, in 1963, FDC pioneered the manufacture of specialized ophthalmic formulations in India. FDC was the first organization to introduce the BFS (Blow-Fill-Seal) technology for ophthalmic in South East Asia. In 1972, FDC initiated the concept of Oral Rehydration Salts (ORS). Today its pioneer brand ‘Electral’ stands apart with a special identity- an impressive achievement in a fiercely competitive market. FDC’s API plant at Roha (Maharashtra) was among the first few API facilities in India to get US-FDA approval in 1984. Since then, FDC has to its credit a number of new molecules, introduced for the first time in the nation.
After its first US FDA inspection in 1985, the company has undergone over 30 extensive audits by regulatory authorities including the US-FDA, UK-MHRA, SA-MCC and ANVISA (Brazil). Most importantly, its facilities have been approved by these authorities on every occasion.
The company’s regulatory experience has refined its operating systems and procedures; simultaneously, the function specific knowledge and competence of its employees continues to grow. It believes in offering only the best quality products, irrespective of whether the market is regulated or not. It has, therefore, built a strong track record of meeting with the most stringent regulatory requirements, enabling it to deliver high-quality APIs and formulations at competitive prices - worldwide.
Product offered by the company
Active Pharmaceutical Ingredients (API) Under Development
Award and Recognition